{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:06:43Z","timestamp":1788862003962,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.euo.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T18:07:58Z","timestamp":1590170878000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["PSMA-PET\/CT\u2013based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy"],"prefix":"10.1016","volume":"4","author":[{"given":"Kilian","family":"Schiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"St\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"D\u00fcsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Borm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Devecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.E.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias M.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen E.","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marciana Nona","family":"Duma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2020.04.004_bib0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"2 Pt 1","key":"10.1016\/j.euo.2020.04.004_bib0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-5347(01)69079-7","article-title":"Cancer control with radical prostatectomy alone in 1,000 consecutive patients","volume":"167","author":"Hull","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.04.004_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0090-4295(96)00167-7","article-title":"Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer","volume":"48","author":"Kupelian","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.euo.2020.04.004_bib0020","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","article-title":"Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.04.004_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2020.04.004_bib0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00330-009-1647-4","article-title":"Imaging of prostate cancer local recurrences: why and how?","volume":"20","author":"Rouvi\u00e8re","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2020.04.004_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","article-title":"The diagnostic value of PET\/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer","volume":"42","author":"Afshar-Oromieh","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2020.04.004_bib0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid (6)(8)Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2020.04.004_bib0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/bju.13397","article-title":"68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment","volume":"117","author":"van Leeuwen","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2020.04.004_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euo.2018.09.010","article-title":"A systematic review on the role of imaging in early recurrent prostate cancer","volume":"2","author":"De Visschere","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.04.004_bib0055","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.04.004_bib0060","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00259-017-3746-9","article-title":"Patterns of failure after radical prostatectomy in prostate cancer\u2014implications for radiation therapy planning after (68)Ga-PSMA-PET imaging","volume":"44","author":"Schiller","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2020.04.004_bib0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","article-title":"Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer","volume":"70","author":"Eiber","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.04.004_bib0070","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","article-title":"68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging","volume":"23","author":"Eder","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.euo.2020.04.004_bib0075","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2018.07.2025","article-title":"FDG\/PET-CT-based lymph node atlas in breast cancer patients","volume":"103","author":"Borm","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2020.04.004_bib0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2020.04.004_bib0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2020.04.004_bib0090","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2011.04.054","article-title":"High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy","volume":"82","author":"Meijer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2020.04.004_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13014-016-0615-9","article-title":"Distribution of prostate nodes: a PET\/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment","volume":"11","author":"Hegemann","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.euo.2020.04.004_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-016-3490-6","article-title":"Comparison of (68)Ga-labelled PSMA-11 and (11)C-choline in the detection of prostate cancer metastases by PET\/CT","volume":"44","author":"Schwenck","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2020.04.004_bib0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000001197","article-title":"68Ga-PSMA-PET\/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET\/CT","volume":"41","author":"Bluemel","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.euo.2020.04.004_bib0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urology.2018.12.055","article-title":"Location of recurrence by gallium-68 PSMA-11 PET scan in prostate cancer patients eligible for salvage radiotherapy","volume":"129","author":"Boreta","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euo.2020.04.004_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00259-015-3240-1","article-title":"Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET\/CT in relation to PSA levels, PSA doubling time and Gleason score","volume":"43","author":"Verburg","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2020.04.004_bib0120","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2016.68.3425","article-title":"Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer","volume":"34","author":"Stish","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.04.004_bib0125","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy","volume":"34","author":"Tendulkar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.04.004_bib0130","series-title":"Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Fr\u00fcherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Version 5.1","author":"DGU","year":"2019"},{"key":"10.1016\/j.euo.2020.04.004_bib0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.euo.2018.11.002","article-title":"Genomic risk predicts molecular imaging-detected metastatic nodal disease in prostate cancer","volume":"2","author":"Xu","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.04.004_bib0140","first-page":"326","article-title":"[Metastatic involvement of pelvic lymph nodes in relation to the morphological differentiation grade and clinical status of prostatic cancer.]","volume":"24","author":"Faul","year":"1985","journal-title":"Der Urologe Ausg A"},{"key":"10.1016\/j.euo.2020.04.004_bib0145","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.04.004_bib0150","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00259-010-1527-9","article-title":"Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer","volume":"37","author":"Vermeeren","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2020.04.004_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4111\/icu.2018.59.2.83","article-title":"Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?","volume":"59","author":"Sivaraman","year":"2018","journal-title":"Invest Clin Urol"},{"key":"10.1016\/j.euo.2020.04.004_bib0160","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.eururo.2016.01.034","article-title":"A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection","volume":"70","author":"Nguyen","year":"2016","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120300523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120300523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:11Z","timestamp":1762876031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931120300523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2588931120300523"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2020.04.004","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSMA-PET\/CT\u2013based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}